ACM
BHC icon

Accipiter Capital Management’s Bausch Health BHC Stock Holding History

Accipiter Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,214,910
Closed -$17.6M – 5
2016
Q4 		$17.6M Sell
1,214,910
-696,700
-36% -$12.8M 14.03% 2
2016
Q3 		$46.9M Sell
1,911,610
-461,600
-19% -$11.9M 22.74% 2
2016
Q2 		$47.8M Buy
2,373,210
+266,831
+13% +$7.56M 39.06% 1
2016
Q1 		$55.4M Buy
2,106,379
+1,872,000
+799% +$138M 31.67% 1
2015
Q4 		$23.8M Buy
+234,379
New +$26.3M 13.02% 2

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Accipiter Capital Management's BHC Position: Q1 2017 in Review

Accipiter Capital Management sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 1,214,910 shares — an estimated $17.6M sold.

Accipiter Capital Management first reported a position in BHC in Q4 2015 and held it in 5 quarters. The position peaked at $55.4M in Q1 2016. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Accipiter Capital Management reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Accipiter Capital Management sold 1,214,910 Bausch Health shares in Q1 2017, an estimated $17.6M.
  • Accipiter Capital Management first reported a position in Bausch Health in Q4 2015 and held it in 5 quarters.
  • Accipiter Capital Management's Bausch Health position peaked at $55.4M in Q1 2016.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Accipiter Capital Management's 13F filing for Q1 2017, filed 15 May 2017.